A detailed history of Perkins Capital Management Inc transactions in Dyadic International Inc stock. As of the latest transaction made, Perkins Capital Management Inc holds 47,850 shares of DYAI stock, worth $83,737. This represents 0.05% of its overall portfolio holdings.

Number of Shares
47,850
Previous 47,850 -0.0%
Holding current value
$83,737
Previous $70,000 30.0%
% of portfolio
0.05%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$1.56 - $2.38 $390 - $595
-250 Reduced 0.52%
47,850 $92,000
Q4 2021

Feb 10, 2022

SELL
$3.36 - $5.34 $672 - $1,068
-200 Reduced 0.41%
48,100 $217,000
Q2 2021

Jul 28, 2021

BUY
$3.35 - $5.67 $2,010 - $3,402
600 Added 1.26%
48,300 $173,000
Q1 2021

Apr 28, 2021

BUY
$4.75 - $6.87 $24,700 - $35,724
5,200 Added 12.24%
47,700 $262,000
Q2 2019

Aug 09, 2019

BUY
$3.15 - $6.95 $133,875 - $295,375
42,500 New
42,500 $266,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $49.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.